Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascale Cornillet-Lefebvre

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Blood|April 12, 2007
Constitutive phosphoinositide 3-kinase/Akt activation represents a favorable prognostic factor in de novo acute myelogenous leukemia patientsJerome Tamburini, Caroline Elie, Valérie Bardet, et al.
Haematologica|April 22, 2011
TET2 mutations in secondary acute myeloid leukemias: a French retrospective studyOlivier Kosmider, Eric Delabesse, Véronique Mansat de Mas, et al.
Plos One|December 20, 2012
High DNA methyltransferase DNMT3B levels: a poor prognostic marker in acute myeloid leukemiaSandrine Hayette, Xavier Thomas, Laurent Jallades, et al.
Blood|April 26, 2018
Clonal interference of signaling mutations worsens prognosis in core-binding factor acute myeloid leukemiaRaphael Itzykson, Nicolas Duployez, Annette Fasan, et al.
Orphanet Journal of Rare Diseases|March 1, 2022
Compound genetic etiology in a patient with a syndrome including diabetes, intellectual deficiency and distichiasisLauriane Le Collen, Brigitte Delemer, Marta Spodenkiewicz, et al.
Molecular Cancer|May 22, 2010
Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemiaEtienne Moussay, Valérie Palissot, Laurent Vallar, et al.
Haematologica|September 22, 2011
High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) studyFrançois Vergez, Alexa S Green, Jerome Tamburini, et al.
Oncoimmunology|December 7, 2017
NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AMLAnne-Sophie Chretien, Raynier Devillier, Cyril Fauriat, et al.
Hemasphere|November 22, 2021
Improvement of Standardization of Molecular Analyses in Hematology: The 10-year GBMHM French ExperienceAnne Sophie Alary, Carole Maute, Olivier Kosmider, et al.
American Journal of Hematology|August 23, 2012
Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: a GOELAMS studyRomain Guièze, Pascale Cornillet-Lefebvre, Bruno Lioure, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Blood|April 12, 2007
Constitutive phosphoinositide 3-kinase/Akt activation represents a favorable prognostic factor in de novo acute myelogenous leukemia patientsJerome Tamburini, Caroline Elie, Valérie Bardet, et al.
Haematologica|April 22, 2011
TET2 mutations in secondary acute myeloid leukemias: a French retrospective studyOlivier Kosmider, Eric Delabesse, Véronique Mansat de Mas, et al.
Plos One|December 20, 2012
High DNA methyltransferase DNMT3B levels: a poor prognostic marker in acute myeloid leukemiaSandrine Hayette, Xavier Thomas, Laurent Jallades, et al.
Blood|April 26, 2018
Clonal interference of signaling mutations worsens prognosis in core-binding factor acute myeloid leukemiaRaphael Itzykson, Nicolas Duployez, Annette Fasan, et al.
Orphanet Journal of Rare Diseases|March 1, 2022
Compound genetic etiology in a patient with a syndrome including diabetes, intellectual deficiency and distichiasisLauriane Le Collen, Brigitte Delemer, Marta Spodenkiewicz, et al.
Molecular Cancer|May 22, 2010
Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemiaEtienne Moussay, Valérie Palissot, Laurent Vallar, et al.
Haematologica|September 22, 2011
High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) studyFrançois Vergez, Alexa S Green, Jerome Tamburini, et al.
Oncoimmunology|December 7, 2017
NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AMLAnne-Sophie Chretien, Raynier Devillier, Cyril Fauriat, et al.
Hemasphere|November 22, 2021
Improvement of Standardization of Molecular Analyses in Hematology: The 10-year GBMHM French ExperienceAnne Sophie Alary, Carole Maute, Olivier Kosmider, et al.
American Journal of Hematology|August 23, 2012
Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: a GOELAMS studyRomain Guièze, Pascale Cornillet-Lefebvre, Bruno Lioure, et al.
Pageof 5